Indian Pharmaceutical Industry Shows Signs of Healthy Growth

Released on = August 2, 2006, 1:39 am

Press Release Author = RNCOS

Industry = Industrial

Press Release Summary = From the confines of a generics market the Indian
pharmaceutical industry has emerged as major player in the world. India's
contribution in the $552 billion global pharma industry is US $6 billion.

Press Release Body = The Indian pharmaceutical industry is fast on its road to
healthy growth. The Indian pharma sector was largely positioned as a generics
market. But now it is transforming to emerge as major contributor in the global
perspective.

The drive of the Indian pharma sector towards its greater share in the global
industry is from its introduction of product patents in 2005. In the last twenty
years, patents were only granted on processes decision. This being to the
disadvantages of many multi-national companies, they exited from the country.
However, it turned advantageous to India, which enabled it to become a leading
producer of generic medicines.

RNCOS' market research report, "Opportunities in Indian Pharma Sector" tells that
the pharmaceutical sector in India currently shares US $6 billion of the total $552
billion global pharmaceutical industry. And this share is poised to grow at a rate
of 12% every year, compared to the annual growth of 8% in the world market. This is
pointed evidence to the promising scenario of the pharmaceutical market in India.

The growth of Indian pharma industry is also driven by the low drug production
costs, which are 55 percent lower than in the western countries. Another reason of
high growth rates is the system of contract manufacturing.

The research report on pharma sector deals with certain critical issues and facts,
which are:
. The emerging trends in the pharmaceutical sector in India.
. The key regulations and policy environment in the industry.
. The future scenario of the pharmaceutical market in India.
. The key players in this market in India.
. The opportunities in Indian pharma sector.
. The challenges faced by the industry.
. Other economic factors affecting the market.

RNCOS' report is based on extensive research that provides objective analysis of
India's pharmaceutical sector performance. The report would be helpful for clients
in analyzing the opportunities prevailing and critical for the growth of this
market. It will also help investors who can refer to the detailed data and analysis
on the changing dynamics of the pharmaceutical industry. The report is a valuable
reference to all concerned with the Indian pharmaceutical industry and its marketing
propensities.
About RNCOS:

RNCOS, incorporated in 2002, provides Market Research Reports for your business
needs and aims to put an end to your information pursuit. Our expertise in gathering
global business information for industry research, corporate training, growth
consulting, and business consulting, brings reputed companies and firms to us for
business enhancement solutions. We can be your one-stop-shop for Industry research
information and niche market analysis.

To purchase your copy: http://www.rncos.com/Report/IM055.htm
For more information about the report please visit www.rncos.com


Web Site = http://www.rncos.com

Contact Details = RNCOS
Shushmul Maheshwari
Head of Business Development
29, 1st Floor, Patparganj Industrial area, Delhi 92
91-11-4214-1229
info@rncos.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •